E
Enanta Pharmaceuticals, Inc.
ENTA · NASDAQ · Healthcare · 383M
Closing price
$12.50
+3.31% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.1×
Enterprise value / EBITDAEV/EBITDA
-6.2×
Free cash flow yieldFCF yield
-12.1%
Return on equityROE
-126.5%
Operating margin
-130.7%
Net debt / EBITDAbalance-sheet strength
-2.4×
Interest coverage
-11.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.